News

We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.

We are delighted to announce that Joanna Nowacka has joined Dynamic42 as Lead for Stem Cell Model Development.

Dynamic42 has launched the “DynamicOrgan System”, an open, flexible, and cost-effective organ-on-chip platform for lab use.

We are excited to announce that Mari Kakihara has joined us recently to support Finance and Controlling.

Dynamic42 GmbH has developed an intestine-on-chip candidiasis model that allows for the quantification of the infection process.

We are excited to announce that Japhette Kembou-Ringert has joined us at the beginning of this year to support our lab team.

Organ-on-chip specialist Dynamic42 GmbH and Biopredic, manufacturer of assay systems for research, announce a strategic Marketing agreement.

We are excited to announce that Noreen Schuck has joined us at the beginning of October to support our lab team.

The first 3R network meeting, organized by the Federal Ministry of Education and Research (BMBF) in Berlin, brought together various experts to discuss current developments, perspectives, and challenges in 3R research.

We are delighted to announce that Dr. Juliane Fischer has joined our team and will from now on heading all Marketing efforts at Dynamic42.

Following their Master’s studies, Daria and Sophie join our lab team as research assistants.

The RUBIN Alliance “ATHANA” (antifungal therapy approaches with nanoparticle-based targeting of drugs) is developing innovative therapeutic approaches for the treatment of infectious diseases, in particular fungal infections.

Innovative organ-on-chip specialist Dynamic42 GmbH has closed a mid-seven-figure financing round.

BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.

A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software.

Jena-based biotech company passes on expertise on future organ-on-chip technology to research institutions and companies

We were featured as a member of medways e.V. in Wirtschaftsspiegel.

In an interview with the trade journal “Laborjournal”, our managing directors explain how the Dynamic42 biotech chips work and how the “mini-organs” used contribute to reducing animal experiments.

An article in the MED Engineering journal explained the potential of our “mini organs” from the laboratory for drug and food testing.

Exciting answers to exciting questions: We were interviewed by bionity and analytica-world. Read it now!

Read the interview with Thomas Stölzel in WirtschaftsWoche.

Find out how our biotech chips are used in food analysis!

You want to know why we are called “Dynamic42”? Take a look at our feature on MDR Thüringen!

At the award ceremony for the XXIII Thuringian Innovation Prize, we were interviewed about our development for the Ostthüringer Zeitung newspaper.

Dynamic42 GmbH has closed a seven-figure start-up financing round – Read more about

We participate in the EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.

The first seed financing in the six-figure range was closed in early summer 2019.

We were awarded the Thuringian Founder’s Prize 2018! We would like to thank everyone who made this possible for us!

We are at Medica in Düsseldorf – Come by and meet us!

Find out how our biotech chips are used in food analysis!

At the EY Public Value Award 2018, Dynamic42 GmbH was awarded the audience prize.